Angela Brand is Full Professor at UNU-MERIT, Maastricht Graduate School of Governance, Faculty of Humanities and Sciences at Maastricht University, The Netherlands, Director of the European Centre for Public Health Genomics (ECPHG) as well as Dr. T.M.Pai Endowed Chair on Public Health Genomics and Adjunct Professor at the School of Life Sciences at Manipal University, India. Before she worked in the clinics, at various academic institutions and in governmental bodies in the USA and Germany. She is Paediatrician, Specialist in Public Health Medicine, holds a PhD in pathology from Münster University, Germany, and a Master of Public Health (MPH) from Johns Hopkins University, USA. She received her habilitation in Public Health Genomics focusing on Health Technology Assessment from Bremen University, Germany. She has been the pioneer of Public Health Genomics in Europe and established successfully this field in more than 15 European Member States within the last years (PHGEN). She is Fellow of the Rockefeller Foundation, USA, Fellow of the 21st Century Trust of the Wellcome Trust, UK, and Member of the New York Academy of Sciences. She is Expert of the International Consortium Personalised Medicine (IC PerMed), Editor-in-Chief of the international Journal Public Health Genomics, Advisory Board Member of the EU Innovation Medicine Initiative (IMI) project OncoTrack, of ALACRiS Theranostics GmbH, and of the Ludwig Boltzmann Institute (LBI) for Health Technology Assessment, Steering Committee Member of the “Forward Look on Personalized Medicine” of the European Science Foundation (ESF), of the Genomic Medicine Alliance (GMA) and of the European Alliance for Personalised Medicine (EAPM). She serves as Expert for the European Medicines Agency (EMA), the OECD, WHO, the EC, the ECDC, the German Robert Koch-Institut (RKI), Genome Canada, Science Europe, AXA Research among others. She collaborates with industry partners such as IBM, Roche, Pfizer, AMGEN, Novartis, MSD, Bayer HealthCare.